BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 7905780)

  • 1. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.
    Bradwejn J
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S109-13. PubMed ID: 7905780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The benzodiazepine receptor: the enigma of the endogenous ligand].
    Pélissolo A
    Encephale; 1995; 21(2):133-40. PubMed ID: 7781584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction. The multiplicity of uses of benzodiazepines.
    Lapierre YD
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S101. PubMed ID: 7905779
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive-behavioral therapy for benzodiazepine discontinuation in panic disorder patients.
    Otto MW; Pollack MH; Meltzer-Brody S; Rosenbaum JF
    Psychopharmacol Bull; 1992; 28(2):123-30. PubMed ID: 1355299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future directions in anxiolytic pharmacotherapy.
    Kunovac JL; Stahl SM
    Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacotherapy of panic disorder].
    Bougerol T; Farisse J
    Encephale; 1996 Dec; 22 Spec No 5():46-53. PubMed ID: 9138947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The right drugs for panic and phobias. Managing anxiety in your patients].
    Stiefelhagen P
    MMW Fortschr Med; 2001 Sep; 143(37):16. PubMed ID: 11599286
    [No Abstract]   [Full Text] [Related]  

  • 11. [The mechanism of action of benzodiazepine and its consequences for therapy].
    Cugurra F
    Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.
    Bailey JE; Papadopoulos A; Seddon K; Nutt DJ
    J Psychopharmacol; 2009 Mar; 23(2):117-22. PubMed ID: 18562427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacotherapy with benzodiazepines: basic principles and new developments].
    Möhler H
    Praxis (Bern 1994); 1998 Feb; 87(6):186-90. PubMed ID: 9531812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary on the mode of action of benzodiazepines.
    Leonard BE
    J Psychiatr Res; 1993; 27 Suppl 1():193-207. PubMed ID: 7908333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.
    Zwanzger P; Rupprecht R
    J Psychiatry Neurosci; 2005 May; 30(3):167-75. PubMed ID: 15944741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need.
    Otto MW; Bruce SE; Deckersbach T
    J Clin Psychiatry; 2005; 66 Suppl 2():34-8. PubMed ID: 15762818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The GABAA/benzodiazepine receptor: implications for the molecular basis of anxiety.
    Breier A; Paul SM
    J Psychiatr Res; 1990; 24 Suppl 2():91-104. PubMed ID: 1980704
    [No Abstract]   [Full Text] [Related]  

  • 19. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
    Chouinard G
    J Clin Psychiatry; 2004; 65 Suppl 5():7-12. PubMed ID: 15078112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acute treatment of anxiety and depression.
    Swinson RP
    Psychiatr J Univ Ott; 1989 Jun; 14(2):375-8; discussion 379-80. PubMed ID: 2569748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.